Previous Article | Next Article ![]()
Journal of Virology, October 2001, p. 9977-9982, Vol. 75, No. 20
Department of Tumor Virology, Institute for
Genetic Medicine, Hokkaido University, N15 W7, Kita-ku, Sapporo
060-0815, Japan
Received 26 March 2001/Accepted 11 July 2001
Transfection of an Epstein-Barr virus (EBV)-encoded plasmid
containing EBER caused a substantial decrease in the level of plasmid
containing EBV in Akata and Mutu Burkitt's lymphoma (BL) lines, but
failed to do so in other BL lines. The results suggest that EBER could
replace the role of EBV, but other EBV products also play a role in the
growth of BL.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9977-9982.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Replacement of the Epstein-Barr Virus Plasmid with
the EBER Plasmid in Burkitt's Lymphoma Cells
*
Corresponding author. Mailing Address: Department of
Tumor Virology, Institute for Genetic Medicine, Hokkaido University, N15 W7, Kita-ku, Sapporo 060-0815, Japan. Phone: 81-11-706-5071. Fax:
81-11-717-1128. E-mail: kentaka{at}med.hokudai.ac.jp.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»